Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
nejm.org
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
Patients with advanced biliary tract cancer have a poor prognosis, and first-linestandard of care (gemcitabine plus cisplatin) has remained unchanged for more than10 years. The TOPAZ-1 trial eval...
Jun 1, 2022
Programmed cell death protein 1 PD-1 and Cancer
Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitors
cancer.gov
Apr 7, 2022
Can the Microbiome Help Predict Immunotherapy Response? | Cancer
Can the Microbiome Help Predict Immunotherapy Response? | Cancer
labroots.com
Mar 11, 2024
What is Necrosis vs What is Apoptosis?
4:44
What is Necrosis vs What is Apoptosis?
YouTubeFreeMedEducation
756.3K viewsMay 27, 2018
Top videos
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
nejm.org
Sep 10, 2022
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new data on progression-free survival, overall survival, and safety from the BREAKWATER phase 3 trial in this 60-Second Journal Club. Read the full trial results: https://nej.md/3ScDaWC | The New England Journal of Medicine
2:20
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new data on progression-free survival, overall survival, and safety from the BREAKWATER phase 3 trial in this 60-Second Journal Club. Read the full trial results: https://nej.md/3ScDaWC | The New England Journal of Medicine
FacebookThe New England Journal of
4K views6 months ago
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: https://nej.md/470x4ix | The New England Journal of Medicine
1:10
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: https://nej.md/470x4ix | The New England Journal of Medicine
FacebookThe New England Journal of
3K views10 months ago
Programmed cell death protein 1 PD-1 Inhibitors
Apoptosis Pathway | Apoptosis Intrinsic Pathway
10:18
Apoptosis Pathway | Apoptosis Intrinsic Pathway
YouTubeShomu's Biology
277.9K viewsNov 24, 2015
Anti–PD-1/PD-L1 therapy of human cancer
1:24
Anti–PD-1/PD-L1 therapy of human cancer
YouTubeProteinlounge
30.3K viewsMar 18, 2016
PD-L1/PD-1 Pathway: A Security Checkpoint
3:29
PD-L1/PD-1 Pathway: A Security Checkpoint
YouTubeGenentech
59.1K viewsApr 25, 2017
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stag…
Sep 10, 2022
nejm.org
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new data on progression-free survival, overall survival, and safety from the BREAKWATER phase 3 trial in this 60-Second Journal Club. Read the full trial results: https://nej.md/3ScDaWC | The New England Journal of Medicine
2:20
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new da…
4K views6 months ago
FacebookThe New England Journal of Medicine
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: https://nej.md/470x4ix | The New England Journal of Medicine
1:10
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes …
3K views10 months ago
FacebookThe New England Journal of Medicine
NEJM This Week — December 11, 2025
27:17
NEJM This Week — December 11, 2025
346 views2 weeks ago
YouTubeNEJM Group
NEJM This Week — November 13, 2025
24:32
NEJM This Week — November 13, 2025
318 views1 month ago
YouTubeNEJM Group
Pitavastatin to Prevent CV Disease in HIV Infection | NEJM
Pitavastatin to Prevent CV Disease in HIV Infection | NEJM
3.1K viewsAug 24, 2023
YouTubeNEJM Group
Subgroup Analyses: Subpar or Sublime? | NEJM Evidence
4:03
Subgroup Analyses: Subpar or Sublime? | NEJM Evidence
6K viewsSep 2, 2022
YouTubeNEJM Group
Tickborne Diseases | NEJM
37.8K viewsMar 29, 2023
YouTubeNEJM Group
The SPRINT Trial
21.5K viewsNov 9, 2015
YouTubeNEJM Group
0:08
Coronary Angiography | NEJM
721.9K viewsSep 6, 2017
YouTubeNEJM Group
1:07
How Does Anti-PD-1 Therapy Help Fight Cancer?
9.5K viewsMay 24, 2017
YouTubeJohns Hopkins Medicine
1:21
Leadless Cardiac Pacemaker | NEJM
231.8K viewsSep 17, 2015
YouTubeNEJM Group
1:26
Pentoxifylline or Prednisolone
29.3K viewsApr 23, 2015
YouTubeNEJM Group
2:12
Cancer immunotherapy | The PD-L1 pathway
213.7K viewsMay 26, 2016
YouTubeRoche
1:16
Explaining Immunotherapy, PD-L1 and PD-1
39.3K viewsSep 14, 2020
YouTubeAmerican Lung Association
4:00
Cancer Immunotherapy - PD-1 and PD-L1
273.1K viewsAug 5, 2014
YouTubeImmunoOncology
2:18
Peripheral Nerve Blocks for Hand Procedures | NEJM
396K viewsJan 19, 2019
YouTubeNEJM Group
1:20
How does PD-L1 impact treatment options for lung cancer?
14.1K viewsSep 14, 2020
YouTubeAmerican Lung Association
57:38
PD-1 and PD-L1 Checkpoint Inhibitor Pathway (Webinar)
6.3K viewsMay 27, 2016
YouTubePhenoPath Laboratories
4:02
Glucagon-like Peptide (GLP-1) - Diabetes Treatment - Semaglutide …
133.3K viewsMay 18, 2017
YouTubeMedicosis Perfectionalis
3:21
PD-L1/PD-1 pathway: a security checkpoint
79.5K viewsSep 9, 2016
YouTubeRoche
6:08
PD-1, PD-L1 role in immune system inhibition
25.6K viewsNov 24, 2015
YouTubeLee Brake
8:15
Peritoneal Dialysis: Percutaneous Implantation In-Service With Flex-…
98.3K viewsApr 3, 2020
YouTubeMerit Medical
16:12
The Plague of Our Time: The HIV/AIDS Epidemic | NEJM
232.1K viewsApr 27, 2012
YouTubeNEJM Group
37:34
Designing First-In-Human Trials for Small Molecules and Biologics
12.5K viewsApr 15, 2021
YouTubeU.S. Food and Drug Administration
5:15
What Is AlphaFold? | NEJM
108.9K viewsSep 21, 2023
YouTubeNEJM Group
18:58
PD-L1 Testing by Immunohistochemistry
12.5K viewsAug 22, 2022
YouTubeMayo Clinic Laboratories
2:17
Dupilumab for COPD | NEJM
12.1K viewsJul 20, 2023
YouTubeNEJM Group
6:21
Bayesian Way | NEJM Evidence
14K viewsApr 26, 2023
YouTubeNEJM Group
See more videos
Static thumbnail place holder